Transvaginal botulinum toxin A (BTA) injection

DRUG2 trials

Sponsors

Stanford University

Conditions

Bladder Pain SyndromeBladder, OveractiveInterstitial CystitisOveractive BladderUrge IncontinenceUrgency UrinaryUrinary Frequency/Urgency

Early Phase 1

Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder

CompletedNCT05463822

Stanford UniversityBladder, Overactive, Overactive Bladder, Urge Incontinence +2

Start: 2019-06-20End: 2021-09-27Updated: 2022-07-19

Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain Syndrome

Active, not recruitingNCT05485207

Stanford UniversityBladder Pain Syndrome, Interstitial Cystitis

Start: 2022-04-04End: 2025-02-28Updated: 2024-04-19